Skip to content

POLYP DETECTION WITH THE PEERSCOPE SYSTEM*: A RANDOMIZED TANDEM COLONOSCOPY STUDY

POLYP DETECTION WITH THE PEERSCOPE SYSTEM*: A RANDOMIZED TANDEM COLONOSCOPY STUDY - PeerScope Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37818
Enrollment
50
Registered
2012-03-26
Start date
2012-04-17
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer screening large bowel observation

Interventions

None listed

Sponsors

PeerMedical Ltd.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Subject between the ages of 18 and 70; • The patient is undergoing colonoscopy for colorectal cancer screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup; • Written informed consent must be available before enrollment in the trial.

Exclusion criteria

Exclusion criteria: • Patients with a history of colonic resection. • Patients with known (or newly diagnosed) inflammatory bowel disease. • Patients with a personal history of polyposis syndrome. • Patients with suspected colonic stricture potentially precluding complete colonoscopy. • Patients with diverticulitis or toxic megacolon. • Patients with a history of radiation therapy to abdomen or pelvis. • Patients with acute lower GI-bleeding. • Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient*s participation in this study. • Pregnant women and women with childbearing potential without adequate contraception.

Design outcomes

Primary

MeasureTime frame
• Standard view colonoscopy additional adenoma detection rate compared to the extended view additional adenoma detection rate using the PeerScope System*. • Standard view colonoscopy additional polyp detection rate compared to the extended view additional polyp detection rate using the PeerScope System*.

Secondary

MeasureTime frame
• Performance of therapeutic interventions, such as biopsies, polypectomies, APC etc. • Procedure time. The following will be recorded: a. Time for intubation to the cecum. b. Time for withdrawal from the cecum to the anal verge. c. Total procedure time. A stopwatch is needed for 4. with stopping the timing of the procedure for any polypectomy performed and then restarting once the polypectomy is completed, meaning that purely procedure time is measured • Sedation dosage. • Patient satisfaction. Patient's pain at the end of the procedure will be recorded using VAS scale. Results of 24 hour telephone follow-up to assess for post-procedural patient satisfactory will be recorded on the CRF.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)